Vanguard Capital Management’s Kairos Pharma KAPA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.9K Sell
9,707
-23,418
-71% -$48.7K ﹤0.01% 4001
2026
Q2
$89K Hold
33,125
– – ﹤0.01% 3886
2026
Q1
$130K Buy
+33,125
New +$155K ﹤0.01% 3841

Other funds holding KAPA

Vanguard Capital Management's KAPA Position: Q3 2026 in Review

Vanguard Capital Management reduced its Kairos Pharma (KAPA) stake by 71% in Q3 2026, selling an estimated $48.7K and leaving 9,707 shares worth $15.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4001.

Vanguard Capital Management first reported a position in KAPA in Q1 2026 and has held it in 3 quarters since. The position peaked at $130K in Q1 2026. 5 funds tracked by Wall St. Rank hold KAPA as of Q3 2026.

  • Vanguard Capital Management held 9,707 shares of Kairos Pharma worth $15.9K as of Q3 2026.
  • Vanguard Capital Management sold 23,418 Kairos Pharma shares in Q3 2026, an estimated $48.7K.
  • Kairos Pharma made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #4001 holding.
  • Vanguard Capital Management first reported a position in Kairos Pharma in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Kairos Pharma position peaked at $130K in Q1 2026.
  • 5 funds tracked by Wall St. Rank held Kairos Pharma as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.